Breanna Burkart | VP, IR |
Patrick Mahaffy | President and CEO |
Dan Muehl | CFO |
Dr. Lindsey Rolfe | EVP, Clinical & Preclinical Development and Pharmacovigilance and CMO |
Tazeen Ahmad | Bank of America |
Peter Lawson | SunTrust |
Kennen MacKay | RBC Capital |
Gena Wang | Barclays |
Yige Guo | Guggenheim Securities |
Andrew Berens | SVB Leerink |
Jing He | G.research |
Joe Catanzaro | Piper Jaffray |
Good morning. My name is James and I will be your conference operator today. At this time, I would like to welcome everyone to the Clovis Oncology First Quarter 2019 Financial Results Call. All lines have been placed on mute to prevent any background noise. And after the speakers' remarks, there will be a question-and-answer session.